Randomized controlled diagnostic trial to assess dRAST time to result and its utility for antimicrobial stewardship recommendation in bacteremic patients

This study addresses a critical challenge in infectious diseases management by evaluating the efficacy of the dRAST system, a rapid antimicrobial susceptibility testing method, in guiding antimicrobial stewardship programs for patients with bloodstream infections. A randomized diagnostic trial was designed to address this objective. Our findings show that the use of dRAST significantly reduces time-to-result, time to antimicrobial stewardship recommendations, and time to appropriate therapy changes, particularly in critically ill patients. These results underline the potential of rapid diagnostic technologies to optimize patient outcomes and enhance antimicrobial stewardship efforts in real-world clinical settings.